Quadrivalent dengue-virus vaccines: challenges and opportunities for India

Lancet Infect Dis. 2024 May;24(5):e270-e271. doi: 10.1016/S1473-3099(24)00137-3. Epub 2024 Feb 23.

Authors

Guruprasad R Medigeshi¹, Farzana Islam², Rakesh Lodha³

Affiliations

¹ Translational Health Science and Technology Institute, Faridabad, India; Indian Institute of Science, Education and Research, Tirupati, India. Electronic address: gmedigeshi@thsti.res.in.
² Department of Community Medicine, Hamdard Institute of Medical Sciences and Research, New Delhi, India.
³ Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.

PMID: 38408459
DOI: 10.1016/S1473-3099(24)00137-3

No abstract available

Publication types

Letter

MeSH terms

Dengue Vaccines* / administration & dosage
Dengue Vaccines* / immunology
Dengue Virus* / immunology
Dengue* / epidemiology
Dengue* / prevention & control
Humans
India / epidemiology

Substances

Dengue Vaccines